Trial Profile
ACTHAR Gel for Chronic Pulmonary Sarcoidosis (ACPS)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Pulmonary sarcoidosis
- Focus Adverse reactions
- 27 Jan 2015 Planned End Date changed from 1 Dec 2016 to 1 Sep 2017 as reported by ClinicalTrials.gov record.
- 27 Jan 2015 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
- 16 Jul 2014 New trial record